Fund Lp Qvt is 10% at ANADYS PHARMACEUTICALS INC (ANDS). They have made 18 open-market trades across 3 companies since 2009, most recently 2011-10-21.
CIK 0001290165
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
13 open-market purchases totalling $5.4M since 2009, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANDS | SELL | 2011-10-20 | 2011-10-24 | $3.68 | $20.7M | N/A | N/A | N/A |
| ANDS | SELL | 2011-10-17 | 2011-10-19 | $3.68 | $2.4M | N/A | N/A | N/A |
| INHX | SELL | 2011-09-26 | 2011-09-28 | $3.00 | $701K | N/A | N/A | N/A |
| INHX | SELL | 2011-04-07 | 2011-04-11 | $4.39 | $2.7M | N/A | N/A | N/A |
| TPCG | SELL | 2010-12-31 | 2011-01-04 | $30.77 | $431K | N/A | N/A | N/A |
| ANDS | BUY | 2010-12-23 | 2010-12-27 | $1.21 | $346K | N/A | N/A | N/A |
| ANDS | BUY | 2010-10-20 | 2010-10-22 | $1.65 | $248K | N/A | N/A | N/A |
| ANDS | BUY | 2010-10-15 | 2010-10-19 | $1.78 | $4.1M | N/A | N/A | N/A |
| ANDS | BUY | 2010-09-01 | 2010-09-03 | $1.74 | $44K | N/A | N/A | N/A |
| ANDS | BUY | 2010-08-25 | 2010-08-27 | $1.72 | $57K | N/A | N/A | N/A |
| ANDS | BUY | 2010-08-19 | 2010-08-23 | $1.79 | $36K | N/A | N/A | N/A |
| ANDS | BUY | 2010-08-03 | 2010-08-05 | $1.99 | $100K | N/A | N/A | N/A |
| ANDS | BUY | 2010-07-06 | 2010-07-08 | $1.98 | $59K | N/A | N/A | N/A |
| ANDS | BUY | 2010-07-02 | 2010-07-06 | $1.94 | $110K | N/A | N/A | N/A |
| INHX | BUY | 2009-12-03 | 2009-12-07 | $0.98 | $45K | N/A | N/A | N/A |
| INHX | BUY | 2009-11-27 | 2009-12-01 | $0.98 | $63K | N/A | N/A | N/A |
| INHX | BUY | 2009-11-11 | 2009-11-13 | $1.00 | $119K | N/A | N/A | N/A |
| INHX | BUY | 2009-11-09 | 2009-11-12 | $0.99 | $83K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.